Return to Article Details
CASE REPORT ABOUT IMMUNOTHERAPY IN MANAGEMENT OF METASTATIC RENAL CANCER: TREATMENT WITH CHECKPOINT PD-L1 AND/OR ANTI-CTLA-4 INHIBITORS